Diagnostic certainty in hypertension

Journal of Hypertension

Volumn 24, Issue 5, 2006, Pages 803-805

  Gatzka, Christoph D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BALLARAT HEALTH SERVICES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 33646379128     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000222744.14208.1c     Document Type: Editorial

References (23)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
2. Kannel WB, Sorlie P, Gordon T. Labile hypertension: a faulty concept? The Framingham study. Circulation 1980; 61:1183-1187.
3. Gerin W, Ogedegbe G, Schwartz JE, Chaplin WF, Goyal T, Clemow L, et al. Assessment of the white-coat effect. J Hypertens 2006; 24:67-74.
4. Parati G, Mancia G. Assessing the white-coat effect: which blood pressure measurement should be considered? J Hypertens 2006; 24:29-31.
5. Parati G, Stergiou GS. Self measured and ambulatory blood pressure in assessing the 'white-coat' phenomenon. J Hypertens 2003; 21:677-682.
6. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2:695-698.
7. Chiu Y-H, Wu S-C, Tseng C-D, et al. Progression of pre-hypertension, stage 1 and 2 hypertension (JNC 7): a Population-based Study in Keelung, Taiwan (Keelung Community-based Integrated Screening no. 9). J Hypertens 2006; 24:821-828.
8. Riva R. Un nuovo sfigmomanometro. Gazetta Medica Lombarda 1896; 55:497.
9. Keith HM, Wagener HP, Barker NW. Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 1939; 191:332-343.
10. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249:2792-2798.
11. Mancia G. Methods for assessing blood pressure values in humans. Hypertension 1983; 5:5-13.
12. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. US Department of Health and Human Services, National Institutes of Health, Publication no. 04-5230; 2004.
13. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata G, Pessina AC. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.
14. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
15. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang Y-L, et al. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006; in press.
16. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
17. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, et al, for the Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21:2251-2257.
18. Public use data tape documentation: physician's examination, tape number 5302 National Health and Nutrition Examination Survey, 1976-80. Maryland, Hyattsville, US Department of Health and Human Services, Public Health Service, National Center for Health Statistics. 1986.
19. Public use data tape documentation: medical history, ages 12-74 years, tape number 5020 National Health and Nutrition Examination Survey, 1976-80. Maryland, Hyattsville, US Department of Health and Human Services, Public Health Service, National Center for Health Statistics. 1985.
20. Dannenberg AL, Garrison PJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health 1988; 78:676-679.
21. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93:697-703.
22. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976-2000. Med Sci Monit 2005; 11:CR403-CR409.
23. National Center for Health Statistics. National Health and Nutrition Examination Survey 1999-2000 Data Files. http://www.cdc.gov/nchs/about/major/nhanes/NHANES99_00.htm [accessed 29 January 2006].